Procalcitonin as an early marker of infection in neonates and children (Q35903215)

11 August 2017

1 reference

title

Procalcitonin as an early marker of infection in neonates and children (English)

1 reference

11 August 2017

A M C van Rossum

1

1 reference

11 August 2017

R W Wulkan

series ordinal

2

1 reference

11 August 2017

A M Oudesluys-Murphy

series ordinal

3

1 reference

11 August 2017

language of work or name

1 reference

1 October 2004

1 reference

Lancet Infectious Diseases

11 August 2017

published in

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

10

1 reference

11 August 2017

page(s)

620-630

1 reference

Clinical applications of C-reactive protein in pediatrics

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

High serum procalcitonin concentrations in patients with sepsis and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin used as a marker of infection in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

[Procalcitonin. A new diagnostic parameter for severe infections and sepsis]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin as a marker of bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Serum procalcitonin as an index of inhalation injury in burns

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Kinetics of procalcitonin in iatrogenic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Clinicopathologic approach to the diagnosis of neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin and C-reactive protein levels in neonatal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin and interleukin‐6 in the diagnosis of early‐onset sepsis of the neonate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Pneumonia in term neonates: laboratory studies and duration of antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Umbilical cord blood serum procalcitonin concentration in the diagnosis of early neonatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Value of Monitoring Serum Procalcitonin in Neonates at Risk of Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture-proven neonatal sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Biochemical markers of neonatal sepsis: value of procalcitonin in the emergency setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin: a marker of neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

lnterleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Lack of specificity of procalcitonin for sepsis diagnosis in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin as a marker for the early diagnosis of neonatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Sepsis terminology in pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin, a marker of bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Use of Quantitative and Semiquantitative Procalcitonin Measurements to Identify Children with Sepsis and Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin as a prognostic marker in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Measurement of Procalcitonin Levels in Children with Bacterial or Viral Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Shock in children with gram-negative bacillary sepsis and Haemophilus influenzae type b sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Pneumonia in pediatric outpatients: cause and clinical manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

C reactive protein in the evaluation of febrile illness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

C-reactive protein in viral and bacterial respiratory infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Serum procalcitonin, adenosine deaminase and its isoenzymes in the aetiological diagnosis of pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Serum procalcitonin in pneumococcal pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin in children admitted to hospital with community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Pneumococcal immune complexes in the diagnosis of lower respiratory infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Oral versus initial intravenous therapy for urinary tract infections in young febrile children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Are younger children at highest risk of renal sequelae after pyelonephritis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Renal cortical scintigraphy in the diagnosis of acute pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Imaging of pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin as a marker of acute pyelonephritis in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin is a marker of severity of renal lesions in pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Bedside Procalcitonin and C-Reactive Protein Tests in Children With Fever Without Localizing Signs of Infection Seen in a Referral Center

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Change in serum procalcitonin (DeltaPct) predicts the clinical outcome of children admitted with febrile neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

The ACCP-SCCM consensus conference on sepsis and organ failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901146-6

7 January 2021

10.1016/S1473-3099(04)01146-6

Identifiers

DOI

1 reference

11 August 2017

1 reference